Physician
Internal Medicine
Dr. Jon R. Monkemeyer, MD
Monkemeyer practices Internal Medicine. He attended University of Illinois College of Medicine. He received awards:"CMS Meaningful Use Stage 1 Certification". Jon R. Monkemeyer is a published MD as well. He has 1 publication published. The latest was: Retinoic acid-induced change in anteroposterior positional identity in regenerating axolotl limbs is dose-dependent. Monkemeyer accepts Medicare payments and is registered with Medicare.gov.
Publications
Schools
University Of Illinois At Rockford
Advocate Lutheran Gen Hospital
Doctors Specialties
Accepted Insurances
- Choice Plus POS II
- American Enterprise Group
- American Republic
- Assurant Health
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Coventry Health Care of Illinois PPO
- Health and Life PPO
- Platinum PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- Health Alliance PPO
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Preferred PPO
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- NGS CoreSource
- Pipefitters
- Thrivent Financial
- Choice Plus POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Advocate Lutheran General Hospital
-
University of Illinois College of Medicine
Drug Facts
NPI NUMBER |
|
1114087731 |
NPPES Provider LastName |
|
MONKEMEYER |
NPPES Provider FirstName |
|
JON |
NPPES Provider ZIPCode |
|
611072574 |
NPPES Provider State |
|
IL |
Specialty Description |
|
Internal Medicine |
Total Claim Count |
|
6202.0 |
Distinct Opioid Count |
|
2.0 |
Opioid Claim Count |
|
237.0 |
Percent Opioid Claims |
|
3.82 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1114087731 |
Last Name Of The Provider |
MONKEMEYER |
First Name Of The Provider |
JON |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog